MYSEUM INC (MYSE) Stock Fundamental Analysis

NASDAQ:MYSE • US23816M2061

1.76 USD
-0.06 (-3.3%)
Last: Feb 20, 2026, 08:00 PM
Fundamental Rating

2

Taking everything into account, MYSE scores 2 out of 10 in our fundamental rating. MYSE was compared to 276 industry peers in the Software industry. The financial health of MYSE is average, but there are quite some concerns on its profitability. MYSE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MYSE had negative earnings in the past year.
  • In the past year MYSE has reported a negative cash flow from operations.
  • MYSE had negative earnings in each of the past 5 years.
  • In the past 5 years MYSE always reported negative operating cash flow.
MYSE Yearly Net Income VS EBIT VS OCF VS FCFMYSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • MYSE has a Return On Assets of -70.05%. This is amonst the worse of the industry: MYSE underperforms 89.86% of its industry peers.
  • MYSE has a Return On Equity of -56.83%. This is in the lower half of the industry: MYSE underperforms 72.10% of its industry peers.
Industry RankSector Rank
ROA -70.05%
ROE -56.83%
ROIC N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
MYSE Yearly ROA, ROE, ROICMYSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • MYSE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MYSE Yearly Profit, Operating, Gross MarginsMYSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K -1M

5

2. Health

2.1 Basic Checks

  • MYSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MYSE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MYSE has been increased compared to 5 years ago.
  • MYSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYSE Yearly Shares OutstandingMYSE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
MYSE Yearly Total Debt VS Total AssetsMYSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • MYSE has an Altman-Z score of -16.52. This is a bad value and indicates that MYSE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -16.52, MYSE is doing worse than 92.39% of the companies in the same industry.
  • MYSE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MYSE (0.00) is better than 65.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.52
ROIC/WACCN/A
WACC11.01%
MYSE Yearly LT Debt VS Equity VS FCFMYSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • MYSE has a Current Ratio of 5.72. This indicates that MYSE is financially healthy and has no problem in meeting its short term obligations.
  • MYSE has a better Current ratio (5.72) than 88.77% of its industry peers.
  • A Quick Ratio of 5.72 indicates that MYSE has no problem at all paying its short term obligations.
  • MYSE has a better Quick ratio (5.72) than 88.77% of its industry peers.
Industry RankSector Rank
Current Ratio 5.72
Quick Ratio 5.72
MYSE Yearly Current Assets VS Current LiabilitesMYSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1

3. Growth

3.1 Past

  • MYSE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.09%, which is quite impressive.
  • MYSE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 20.00%.
EPS 1Y (TTM)35.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.65%
Revenue 1Y (TTM)20%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%200%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYSE Yearly Revenue VS EstimatesMYSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10K 20K 30K 40K

0

4. Valuation

4.1 Price/Earnings Ratio

  • MYSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSE Price Earnings VS Forward Price EarningsMYSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSE Per share dataMYSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for MYSE!.
Industry RankSector Rank
Dividend Yield 0%

MYSEUM INC

NASDAQ:MYSE (2/20/2026, 8:00:01 PM)

1.76

-0.06 (-3.3%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.32%
Inst Owner ChangeN/A
Ins Owners4.53%
Ins Owner Change9.31%
Market Cap7.50M
Revenue(TTM)600
Net Income(TTM)-4.74M
AnalystsN/A
Price TargetN/A
Short Float %3.12%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12496
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-1.03
OCFYN/A
SpS0
BVpS1.96
TBVpS1.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.05%
ROE -56.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.72
Quick Ratio 5.72
Altman-Z -16.52
F-Score4
WACC11.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%200%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.28%
OCF growth 3YN/A
OCF growth 5YN/A

MYSEUM INC / MYSE FAQ

What is the ChartMill fundamental rating of MYSEUM INC (MYSE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSE.


What is the valuation status of MYSEUM INC (MYSE) stock?

ChartMill assigns a valuation rating of 0 / 10 to MYSEUM INC (MYSE). This can be considered as Overvalued.


Can you provide the profitability details for MYSEUM INC?

MYSEUM INC (MYSE) has a profitability rating of 0 / 10.


What is the financial health of MYSEUM INC (MYSE) stock?

The financial health rating of MYSEUM INC (MYSE) is 5 / 10.